(Q38496156)

3 September 2017

title

Evaluation of anti-scratch properties of oxatomide and epinastine in mice (English)

1 reference

3 September 2017

Inagaki N

1

1 reference

3 September 2017

Nagao M

2

1 reference

3 September 2017

Nakamura N

3

1 reference

3 September 2017

Kawasaki H

4

1 reference

3 September 2017

Igeta K

5

1 reference

3 September 2017

Musoh K

6

1 reference

3 September 2017

Nagai H

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

European Journal of Pharmacology

3 September 2017

published in

1 reference

3 September 2017

volume

400

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

73-79

1 reference

Antihistamine activity and central effects of WAL 801 CL in man.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Oxatomide effects in follicular conjunctivitis of presumed allergic cause. A double-blind evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Oxatomide in the treatment of pruritus senilis. A double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

The effects of substance P on histamine and 5-hydroxytryptamine release in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Homologous passive cutaneous anaphylaxis in various strains of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Scratching behavior induced by pruritogenic but not algesiogenic agents in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

An immunopharmacological study of the biphasic allergic skin reaction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

The effect of anti-tumor necrosis factor (TNF)-alpha monoclonal antibody on allergic cutaneous late phase reaction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

Oxatomide inhibits the release of chemical mediators from human lung tissues and from granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900349-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00349-6

1 reference

3 September 2017

1 reference